Morning Market Editorial: Biotech, Bitcoin, and AI – Small-Caps Make Big Moves

September 11, 2025

DENVER, Colo., Sep 11, 2025 (247marketnews.com)- Wall Street opened with a fresh dose of momentum from a slate of high-impact small-cap developments, where biotech meets blockchain, and AI is proving to be more than just a buzzword.

LIXTE Biotechnology (NASDAQ:LIXT) announced a bold pivot into digital assets. The clinical-stage pharmaceutical company disclosed it had acquired 10.5 Bitcoin (BTC) and 300 Ethereum (ETH), totaling approximately $2.6 million, now representing 43.6% of its treasury. The move is part of a broader strategy to enable “transactions across a wide spectrum of mediums,” with the board approving up to 50% of treasury allocation to crypto.

The market is rewarding LIXTE’s moves, as it hit a new 52-week high, yesterday, as traders speculated on a potential sustainable short squeeze run and anticipated Phase 2 news.

Silexion Therapeutics (NASDAQ:SLXN) posted encouraging preclinical data on SIL204, its lead RNAi therapy, showing systemic distribution to major metastatic sites in pancreatic cancer, including the liver, peritoneum, and lungs, with measurable reductions in tumor burden at clinically relevant doses.

Chief Scientific Officer Mitchell Shirvan emphasized the results as “validation for a critical component” of their dual-route delivery strategy. With a Phase 2/3 trial expected to begin in H1 2026, Silexion continues to build credibility in a notoriously difficult oncology space.

Amesite (NASDAQ:AMST) soared after reporting 63% revenue growth for its NurseMagic platform, now gaining traction with enterprise clients. The launch of its AI-powered form-fill tool, targeted at easing the upcoming CMS HOPE documentation burden, positions the company at the intersection of regulatory compliance and operational efficiency in post-acute care.

VP of Sales Brandon Owens said the enterprise model opens up a “much larger addressable market,” as clients look to reduce costs while staying compliant. With AI automating a labor-intensive process, Amesite may be well-timed for the October regulatory shift.

Profusa (NASDAQ:PFSA) announced a strategic collaboration with NVIDIA (NASDAQ:NVDA) to build an AI-driven physician portal leveraging the Lumee oxygen-sensing platform. Powered by NVIDIA NeMo, the system will integrate real-time biometrics into clinical workflows, offering “agentic clinical assistance,” EMR integration, and policy-aware guardrails.

Set for an early 2026 rollout in the EEA, the technology aims to redefine remote patient monitoring and clinical decision-making. Profusa’s CEO Ben Hwang called it “a data-set currently missing” in healthcare AI and investors appear intrigued.

MOGU (NYSE:MOGU), the Chinese KOL-driven lifestyle platform, joined the crypto tide with board approval to allocate up to $20 million into Bitcoin, Ethereum, Solana, and related investment products. The company sees digital assets as a strategic layer in building AI-driven commerce infrastructure.

With Chairman Chen Qi authorized to time the acquisitions, MOGU is betting that blockchain fluency will be critical for next-gen e-commerce.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by Microcap Advisory for providing ongoing LIXT market outreach and other services. Please review our Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (LIXT, SLXN, AMST, PFSA, NVDA, MOGU)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.